Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06263387
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2023-12-14
Brief Title:
Results From a French Temporary Utilization Authorization of First-line Acute Myeloid Leukemia AML Patients Ineligible for Intensive Chemotherapy IC Treated With Venetoclax Azacitidine
Sponsor:
French Innovative Leukemia Organisation
Organization:
French Innovative Leukemia Organisation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-20
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-12-14
First Submit QC Date:
February 15 2024
Study First Post Date:
2024-02-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-22
Last Update Post Date:
2024-06-20
Last Update Post Date Type:
ACTUAL